Thus, we believe that the inflammatory mechanisms dependent on TLR2/TLR6 axis may contribute to the progression towards more severe forms of the disease in morbidly patients with a borderline diagnosis of NASH. The gene discussed is TLR6; the disease is metabolic dysfunction-associated steatohepatitis.